Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype

被引:96
作者
Biancalana, V [1 ]
Caron, O
Gallati, S
Baas, F
Kress, W
Novelli, G
D'Apice, MR
Lagier-Tourenne, C
Buj-Bello, A
Romero, NB
Mandel, JL
机构
[1] Fac Med Strasbourg, Lab Diagnost Genet, Strasbourg, France
[2] CHRU, Strasbourg, France
[3] Univ Bern, Dept Pediat & Clin Res, Bern, Switzerland
[4] Neurogenet Lab, Amsterdam, Netherlands
[5] Univ Wurzburg, Inst Humangenet, Wurzburg, Germany
[6] Univ Roma Tor Vergata, Fac Med & Chirurg, Cattedra Genet Umana, Rome, Italy
[7] Univ Louis Pasteur Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France
[8] Grp Hosp Pitie Salpetriere, Inst Myol, Federat Neurol, F-75634 Paris, France
关键词
D O I
10.1007/s00439-002-0869-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
X-linked myotubular myopathy is characterised by neonatal hypotonia, muscle weakness and respiratory distress in affected males, leading often to early death, although prolonged survival is observed in milder fonns, or as a result of prolongation of ventilation support. It is caused by mutations in the MTM1 gene, which encodes a phosphatase called myotubularin, which has been highly conserved during evolution, down to yeasts (S. cerevisiae and S. pombe). To date, 251 mutations have been identified in unrelated families, corresponding to 158 different disease-associated mutations, which are widespread throughout the gene. We have found additional mutations in 77 patients, including 35 novel ones. We identified a missense mutation N180K in a 67-year-old grandfather (the oldest known patient with an MTM1 mutation), previously suspected to have autosomal centronuclear myopadthy, and in his two grandsons also mildly affected. Mild and moderate phenotypes associated with novel missense mutations and with a translation initiation defect mutation are discussed, as well as severe phenotypes associated with particular novel mutations. With the present report, 192 different mutations in the MTM1 gene have been described in 328 families. The spectrum of mutations is now enlarged from the very severe classic neonatal phenotype to very mild phenotype allowing survival to the age of 67 years.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 28 条
  • [1] Antonarakis SE, 1998, HUM MUTAT, V11, P1
  • [2] Barth P G, 1998, Eur J Paediatr Neurol, V2, P49
  • [3] Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway
    Blondeau, F
    Laporte, J
    Bodin, S
    Superti-Furga, G
    Payrastre, B
    Mandel, JL
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (15) : 2223 - 2229
  • [4] Buj-Bello A, 1999, HUM MUTAT, V14, P320, DOI 10.1002/(SICI)1098-1004(199910)14:4<320::AID-HUMU7>3.0.CO
  • [5] 2-O
  • [6] Listening to silence and understanding nonsense: Exonic mutations that affect splicing
    Cartegni, L
    Chew, SL
    Krainer, AR
    [J]. NATURE REVIEWS GENETICS, 2002, 3 (04) : 285 - 298
  • [7] Nomenclature for the description of human sequence variations
    den Dunnen, JT
    Antonarakis, E
    [J]. HUMAN GENETICS, 2001, 109 (01) : 121 - 124
  • [8] Rapid scanning of myotubularin (MTM1) gene by denaturing high-performance liquid chromatography (DHPLC)
    Flex, E
    De Luca, A
    D'Aspice, MR
    Buccino, A
    Dallapiccola, B
    Novelli, G
    [J]. NEUROMUSCULAR DISORDERS, 2002, 12 (05) : 501 - 505
  • [9] Medical complications in long-term survivors with X-linked myotubular myopathy
    Herman, GE
    Finegold, M
    Zhao, W
    de Gouyon, B
    Metzenberg, A
    [J]. JOURNAL OF PEDIATRICS, 1999, 134 (02) : 206 - 214
  • [10] Characterization of mutations in fifty North American patients with X-linked myotubular myopathy
    Herman, GE
    Kopacz, K
    Zhao, W
    Mills, PL
    Metzenberg, A
    Das, S
    [J]. HUMAN MUTATION, 2002, 19 (02) : 114 - 121